John N. Shell
9Patents
9h-index
4Co-inventors
58Inventor score
Filing activity: Feb 1, 2002 → Mar 9, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6682759B2 | Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs | Human Necessities | 120 | Expired |
| US8329215B2 | Shell and core dosage form approaching zero-order drug release | Human Necessities | 32 | Active |
| US8945619B2 | Shell-and-core dosage form approaching zero-order drug release | Human Necessities | 28 | Active |
| US8043630B2 | Shell-and-core dosage form approaching zero-order drug release | Human Necessities | 26 | Active |
| US7736667B2 | Shell-and-core dosage form approaching zero-order drug release | Human Necessities | 24 | Expired |
| US8685450B2 | Dual drug dosage forms with improved separation of drugs | Human Necessities | 13 | Active |
| US9572780B2 | Dual drug dosage forms with improved separation of drugs | Human Necessities | 11 | Active |
| US8999388B2 | Dual drug dosage forms with improved separation of drugs | Human Necessities | 11 | Active |
| US9597338B2 | Shell-and-core dosage form approaching zero-order drug release | Human Necessities | 9 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.